Role of anti-aromatase agents in postmenopausal advanced breast cancer Robin Murray Original Article Pages: 259 - 265
A phase II study of Caelyx, liposomal doxorubicin: lack of activity in patients with advanced gastric cancer Anne L. ThomasKen O'ByrneWilliam P. Steward Original Article Pages: 266 - 268
Phase I trial of the matrix metalloproteinase inhibitor BAY12-9566 in patients with advanced solid tumors Elisabeth I. HeathSeamus O'ReillyLouise B. Grochow Original Article Pages: 269 - 274
Phase I trial of lobradimil (RMP-7) and carboplatin in children with brain tumors Katherine E. WarrenMahendra C. PatelFrank M. Balis Original Article Pages: 275 - 282
Combined effects of docetaxel and fluoropyrimidines on tumor growth and expression of interleukin-6 and thymidine phosphorylase in breast cancer xenografts Shigeru YamamotoJunichi KurebayashiHiroshi Sonoo Original Article Pages: 283 - 288
Maturation of dendritic cells from ovarian cancer patients Eva ZavadovaCherylyn A. SavaryRalph S. Freedman Original Article Pages: 289 - 296
The use of serum levels of cardiac troponin T to compare the protective activity of dexrazoxane against doxorubicin- and mitoxantrone-induced cardiotoxicity Eugene H. HermanJun ZhangVictor J. Ferrans Original Article Pages: 297 - 304
Changes in the expression and binding properties of the estrogen receptor in MCF-7 breast cancer cells during growth inhibition by tamoxifen and cisplatin Angela M. OttoSybilla SchubertRoland Netzker Original Article Pages: 305 - 311
Co-amplification of dhfr and a homologue of hmsh3 in a Chinese hamster methotrexate-resistant cell line correlates with resistance to a range of chemotherapeutic drugs Bhaswati PanditMadhumita RoyNitai P. Bhattacharyya Original Article Pages: 312 - 318
Antitumor efficacy of 26-fluoroepothilone B against human prostate cancer xenografts Robert A. NewmanJun YangNora M. Navone Original Article Pages: 319 - 326
Etoposide induction of tumor immunity in Lewis lung cancer Lewis M. SlaterMarie StupeckyEdward R. Arquilla Original Article Pages: 327 - 332
Influence of the interval between the administration of doxorubicin and paclitaxel on the pharmacokinetics of these drugs in patients with locally advanced breast cancer António MoreiraRosário LobatoJosé Passos-Coelho Clinical Trial Report Pages: 333 - 337